NORCHOL-131
(131I) IODOMETHYLNORCHOLESTEROL
| Pharmaceutical form | Injection |
| Nuclide | Iodine 131 |
| Half life | 8.02 days |
| Availability | Thursday |
| Ordering deadline | Friday, before 11 a.m. |
| Radioactive concentration | 7.5 - 15 MBq/mL at calibration |
| Calibration | Wednesday 12 a.m. |
| Available quantities | From 37 to 185 MBq per vial at calibration |
| Expiry | 14 days from the manufacturing date |
| Specific activity | 11 - 33 MBq/mg |
| Radiochemical purity | ≥ 85 % |
| Radionuclidic purity | ≥ 99.9 % |
| pH | 3.5 to 8.5 |
| Storage | At - 18°C |
| Indication | • Diagnostic evaluation of the functional state of adrenal cortical tissue • Differentiation between metastatic disease to the adrenals (“cold area”) and non-malignant adrenal enlargement in cancer patients • Detection of remnants of functioning tissue in hypercortisonism from adrenalectomy, or of ectopic endocrine tissue • Detection and follow-up of euadrenal tumours |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
